-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Perspective Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2014 to Q1 2024.
- Perspective Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $346K, a 92.2% increase year-over-year.
- Perspective Therapeutics, Inc. annual Depreciation for 2023 was $946K, a 254% increase from 2022.
- Perspective Therapeutics, Inc. annual Depreciation for 2022 was $267K, a 79.2% increase from 2021.
- Perspective Therapeutics, Inc. annual Depreciation for 2021 was $149K, a 1.36% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)